In the major form of Alzheimer's disease:

In comparison with the extrinsic apoptosis pathway, the intrinsic:

The anti-epileptic drug phenytoin, undergoes metabolism by the CYP450 enzyme, 2C9. 

A patient who has been stable on phenytoin for several months, is prescribed a short course of fluconazole to treat a fungal infection.  Fluconazole is a 2C9 inhibitor.

If taking phenytoin and fluconazole at the same time, which one of the following is this patient MOST LIKELY to be at risk of? 

Which one of the following drugs is MOST commonly used as a therapy for Alzheimer’s disease, due to its favourable pharmacokinetic and pharmacodynamic profile?

The following is a cause/relationship question, which includes two statements - an assertion and a reason. 

You must establish whether each individual statement of the pair is true or false, and then determine whether there is a relationship between the two, ie. does the reason (the second statement) provide an explanation for the assertion (first statement)?

Under physiological conditions, intracellular levels of adenosine are kept low

BECAUSE

Adenosine metabolism is tightly regulated by HIF-1α under physiological conditions

Which one of the following statements about drugs used for the treatment of epilepsy is CORRECT?

Which one of the following statements relating to cholinesterase inhibitors used for treating Alzheimer's disease is CORRECT?

George presented to the emergency department with neurological symptoms including visual disturbances and numbness in the arms and hands. The neurologist suspects multiple sclerosis (MS) and orders some diagnostic tests to confirm.

Which one of the following would NOT be utilised for an MS diagnosis? 

Patient G has experienced a suspected stroke and is taken to the emergency department.

Within 3 hours of the symptoms starting, scans confirm an ischaemic stroke, where a clot is blocking a large cerebral artery.

Which one of the following is Patient G MOST LIKELY to be treated with first?

Which one of the following is TRUE of amyotrophic lateral sclerosis (ALS)?